Summary

Report Overview
North America Infusion Pumps Market reached US$ 1.31 billion in 2023 and is expected to reach US$ 3.2 billion by 2031, growing at a CAGR of 4.3% during the forecast period 2024-2031.
Infusion pumps are utilized extensively in the home and clinical environments such as nursing homes and hospitals. In contrast to manual administration, they provide numerous benefits, including the ability to administer fluids in minute quantities and at precisely programmed or automated intervals. They are utilized to administer medications or nutrients, including antibiotics, insulin or other hormones, painkillers, and chemotherapy medicines. 
Infusion pumps allow for highly viscous medications to be administered through small catheters into the veins. Medication is usually administered this way through the dorsal veins of the hand, the forearm, the arm, the dorsal veins of the foot, the inguinal region, and the antecubital fossa.
Market Dynamics: Drivers & Restraints
Increasing geriatric population 
The rising geriatric population is expected to be the significant driving factor for the market growth. Several diseases are increasing among elderly individuals. Older age is also characterized by the emergence of several complex health states commonly called geriatric syndromes.
Diabetes is one of the major diseases that attacks elderly individuals. To maintain the glucose levels in the patients, infusion pumps are used for insulin infusion and are adopted in homecare settings. IV fluids are used in the treatment of dehydration, a common cause of hospitalization and death in elderly adults particularly among those in nursing homes and at homes using infusion pumps. IV fluids can help meet the nutrition demands of patients who require an alternative to, or supplemental, oral or enteral nutrition.
Cancer is also considered the major diseases that attack older individuals and increase the demand for infusion pumps. Infusion pumps give a controlled amount of drugs very slowly into the bloodstream. There is an increasing demand for infusion pumps among older individuals. The incidence of cancer rises dramatically at a later stage in life. For instance, according to a report by the Union for International Cancer Control, it is stated that in 2022, about 53% of people who had cancer were 65 or older.
Regulatory hurdles
Regulatory challenges associated with approving infusion pumps are expected to hinder the market growth. Ensuring that infusion pumps meet stringent regulatory standards experiences significant costs. These can include costs associated with clinical studies, documentation, quality control methods, and GMP compliance. These fees can be expensive for smaller companies or startups. 
Market Segment Analysis
The North America infusion pumps market is segmented based on product type, application, and end-user.
The insulin infusion pumps segment is expected to dominate the market share
Insulin infusion pumps hold a significant portion of the market share and are expected to continue throughout the forecast period. This is due to the increasing adoption of infusion pumps in the treatment of diabetic patients. The growing number of diabetic patients is also expected to be one of the major factors for the increasing demand for infusion pumps. 
For instance, according to the report by the Centers for Disease Control & Prevention in 2024, it stated that an estimated 11.6% of the US population in 2022 which is about 34 million people. Insulin pumps can help people with diabetes conveniently manage their blood sugar. These small, wearable devices deliver doses of insulin at specific times and are an alternative to multiple daily injections.
The rising diabetic population is increasing the demand for insulin infusion pumps to deliver the correct dosages of insulin to patients. Thus, the above factors are expected to drive the segment growth and are expected to hold the segment in the dominant position.
Market Segmentation
By Product Type
Implantable Infusion Pumps
Insulin Infusion Pumps
Syringe Infusion Pumps
Volumetric Infusion Pumps
Others 
By Application
Diabetes
Chemotherapy/Oncology
Gastroenterology
Analgesia/Pain Management
Pediatrics/Neonatology
Hematology
Others
By End-User
Hospitals & Clinics
Ambulatory Care Settings
Home Care Settings
Academic & Research Institutes
Others
Market Competitive Landscape
The major players in the market include JMS North America Corporation, Micrel Medical Devices SA, Biomedix Medical, Inc., Moog Inc., Becton, Dickinson and Company, Medtronic Plc, Smiths Group plc, Fresenius Kabi USA, Baxter International Inc., and B. Braun Medical Inc. among others.
Why Purchase the Report?
To visualize the North America infusion pumps market segmentation based on product type, application, and end-user, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development. 
Excel data sheet with numerous data points of infusion pumps market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.
The North America infusion pumps market report would provide approximately 53 tables, 47 figures, and 176 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing geriatric population
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Regulatory hurdles
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Implantable Infusion Pumps*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Insulin Infusion Pumps
6.4. Syringe Infusion Pumps
6.5. Volumetric Infusion Pumps
6.6. Others
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Diabetes*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Chemotherapy/Oncology
7.4. Gastroenterology
7.5. Analgesia/Pain Management
7.6. Pediatrics/Neonatology
7.7. Hematology
7.8. Others
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals & Clinics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Care Settings
8.4. Home Care Settings
8.5. Academic & Research Institutes
8.6. Others
9. Competitive Landscape
9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis
10. Company Profiles
10.1. JMS North America Corporation*
10.1.1. Company Overview
10.1.2. Product Portfolio and Description
10.1.3. Financial Overview
10.1.4. Key Developments
10.2. Micrel Medical Devices SA
10.3. Biomedix Medical, Inc.
10.4. Moog Inc.
10.5. Becton, Dickinson, and Company
10.6. Medtronic Plc
10.7. Smith’s Group plc
10.8. Fresenius Kabi USA
10.9. Baxter International Inc.
10.10. B. Braun Medical Inc. (*LIST NOT EXHAUSTIVE)
11. Appendix
11.1. About Us and Services
11.2. Contact Us